Skip to content

Valerian for Conscious Sedation in Patients Submitted to Impacted Lower Third Molars Surgery

Valeriana Officinalis L. for Conscious Sedation in Patients Submitted to Impacted Lower Third Molars Surgery: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01612130
Enrollment
20
Registered
2012-06-05
Start date
2003-03-31
Completion date
2003-08-31
Last updated
2012-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Anxiety, Blood Pressure, Heart Rate

Brief summary

The aim of the present study was to evaluate the efficacy of Valeriana officinalis L. 100 mg in single oral doses one hour preoperative as conscious sedation during the impacted lower third molar surgery.

Detailed description

Evaluate the efficacy of Valeriana officinalis L. (Valerian) for control of anxiety during third molar surgery. Study design: A single oral dose of either valerian (100 mg) or placebo was randomly administered one hour before each surgical procedure to 20 volunteers between 17 and 31 years of age. Anxiety level was assessed through questionnaires, physiological parameters (blood pressure and heart rate) and the observation of signs.

Interventions

DRUG100 mg of Valeriana officinalis L

A single dose of 100 mg of Valeriana officinalis L., 1 hour prior to surgical procedures

A single dose of 100 mg of placebo orally, 1 hour prior to surgical procedures

Sponsors

University of Campinas, Brazil
CollaboratorOTHER
Federal University of the Valleys of Jequitinhonha and Mucuri
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Indication for bilateral extraction of asymptomatic impacted mandibular third molars in similar positions based on the Pell & Gregory classification

Exclusion criteria

* Use of any type of medication in the 15 days prior to the onset of the study; history of hypersensitivity to the drugs, substances or materials employed in the experiment; pregnancy or lactation

Design outcomes

Primary

MeasureTime frameDescription
Signs and symptoms of anxiety1 day (during dental appointment)During each surgery, the researcher and surgeon observed the manifestation of signs and symptoms associated to anxiety (restlessness/agitation/nervous ticks, paleness, excessive perspiration, tingling sensation in hands, feet or lips, change in breathing rhythm or depth). In the presence of one or more of these signs and symptoms, the patient was classified as anxious. If there was no manifestation of anxiety, the patient was classified as calm or relaxed
assessment of the blood pressure1 day (during dental appointment)The assessment of the blood pressure was performed at three moments: baseline, post-medication and end of surgery.
Assesment of heart rate1 day (during dental appointment)The assessment of the heart rate was performed at three moments: baseline, post-medication and end of surgery.

Secondary

MeasureTime frameDescription
Oxygen saturation1 day (During dental appointment)Level of blood oxygen saturation 30 minutes after drug administration and throughout the surgical procedure.
Side effects of drugs1 weekEvaluation of the incidence of side effects of drugs used were informed by the patient after de drug administration until one week of postoperative period.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026